German plant aims to make up to 10 mln doses of Sputnik V vaccine monthly by year-end
Reuters
7 hrs ago
* R-Pharm aims to launch production in Germany in Q4
* Targets initial output of 4-5 mln doses per month
* Russian vaccine is under rolling review by EU regulator
By Polina Nikolskaya and Polina Ivanova
MOSCOW, April 9 (Reuters) - Russian pharmaceutical firm R-Pharm expects to produce up to 8-10 million doses monthly of the Sputnik V vaccine against COVID-19 at its plant in Bavaria, southern Germany, when operating at full capacity, its chief executive told Reuters.
Germany is gearing up to start bilateral negotiations with Russia to obtain supplies of the vaccine, Reuters reported on Wednesday, though a final decision would depend on approval of the shot by the European Medicines Agency (EMA).